1.45
price up icon6.62%   0.09
after-market Handel nachbörslich: 1.45
loading

Finanzdaten der Erasca Inc-Aktie (ERAS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
14.70%
38.85
33.87 34.66 35.97 37.02
Operating Income/Loss
14.70%
-38.85
-33.87 -34.66 -35.97 -37.02
Nonoperating Income/Loss
8.08%
3.834
4.171 4.297 4.189 3.826
Income/Loss From Continuing Operations Before Tax
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Net Income/Loss
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
81,883%
151.16
0.1844 150.45 150.04 149.50
Diluted Average Shares
81,883%
151.16
0.1844 150.45 150.04 149.50
Basic Earnings Per Share
21.05%
-0.23
-0.19 -0.20 -0.21 -0.22
Diluted Earnings Per Share
21.05%
-0.23
-0.19 -0.20 -0.21 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):